These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1450 related items for PubMed ID: 26043748

  • 1. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 2. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB, Xu Y, Chen LG, Guan TP, Ma YY, He XJ, Xia YJ, Tao HQ, Shao QS.
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P, Huang H, Chang J, Zhao GF, Lu ML, Wang Y.
    World J Gastroenterol; 2013 May 07; 19(17):2697-703. PubMed ID: 23674878
    [Abstract] [Full Text] [Related]

  • 4. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX, Ding L, Lin Y, Shu M, Wen JM, Xue L.
    J Clin Pathol; 2015 May 07; 68(5):374-80. PubMed ID: 25731189
    [Abstract] [Full Text] [Related]

  • 5. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
    Zhang L, Qiu M, Jin Y, Ji J, Li B, Wang X, Yan S, Xu R, Yang D.
    Int J Clin Exp Pathol; 2015 May 07; 8(9):11084-91. PubMed ID: 26617827
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H, Li C, Cai S, Zhu C, Tian Y, Zheng J, Hu J, Chen C, Liu W.
    Hepatogastroenterology; 2014 May 07; 61(133):1478-82. PubMed ID: 25436328
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.
    World J Gastroenterol; 2015 Feb 14; 21(6):1838-44. PubMed ID: 25684949
    [Abstract] [Full Text] [Related]

  • 8. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
    Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R.
    World J Gastroenterol; 2015 Feb 21; 21(7):2159-68. PubMed ID: 25717252
    [Abstract] [Full Text] [Related]

  • 9. TPX2 expression is associated with poor survival in gastric cancer.
    Tomii C, Inokuchi M, Takagi Y, Ishikawa T, Otsuki S, Uetake H, Kojima K, Kawano T.
    World J Surg Oncol; 2017 Jan 09; 15(1):14. PubMed ID: 28069036
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR, Sun Z, Zhu Z, Guan HX, Li CY, Zhang JY, Zhang YN, Zhou H, Zhang HJ, Xu HM, Sun MJ.
    World J Gastroenterol; 2015 May 07; 21(17):5336-44. PubMed ID: 25954108
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.
    Liu L, Yang Z, Zhang W, Yan B, Gu Q, Jiao J, Yue X.
    Tumour Biol; 2014 Sep 07; 35(9):8875-81. PubMed ID: 24894674
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC.
    World J Gastroenterol; 2015 Jan 14; 21(2):571-7. PubMed ID: 25593477
    [Abstract] [Full Text] [Related]

  • 16. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P, Lu Y, Liu L.
    Int J Clin Exp Pathol; 2015 Jan 14; 8(5):5230-5. PubMed ID: 26191222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
    Jiang YX, Li PA, Yang SW, Hao YX, Yu PW.
    Int J Clin Exp Pathol; 2015 Jan 14; 8(6):7002-8. PubMed ID: 26261590
    [Abstract] [Full Text] [Related]

  • 19. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
    Xu CC, Yue L, Wei HJ, Zhao WW, Sui AH, Wang XM, Qiu WS.
    Pathol Res Pract; 2013 Aug 14; 209(8):479-85. PubMed ID: 23822993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.